Basic Metformin Glyburide Information

• INN (International Nonproprietary Name): Metformin and Glyburide
• Brand Names Available In Canada (English): Apo-Glyburide/Metformin, Ratio-Glyburide/Metformin; manufacturers include Apotex and Sandoz.
• ATC Code: A10BD03 — A10: Drugs used in diabetes; A10B: Blood glucose lowering drugs, excl. insulins; A10BD: Combinations of oral blood glucose lowering drugs.
• Forms & Dosages: Oral tablets in strengths 1.25mg/250mg, 2.5mg/500mg and 5mg/500mg.
• Manufacturers In Canada (English): Apotex and Sandoz (generics predominate).
• Registration Status In Canada (English): Authorized by Health Canada; several generics available.
• OTC / Rx Classification: Prescription only (Rx) globally, including Canada.

Instructions And Warnings For Canadian Patients

This combination pill is prescription-only in Canada; check Health Canada approval and confirm your pill’s Drug Identification Number (DIN) with your pharmacist before starting.

Avoid this medicine if your estimated glomerular filtration rate (eGFR) is less than 30 mL/min due to the risk of lactic acidosis and metformin accumulation.

Do not use it during acute serious illness, when dehydrated, or if there is any suspected lactic acidosis.

If you experience dizziness, severe nausea, rapid breathing, muscle pain or seizures, seek emergency care immediately and tell clinicians you take metformin and glyburide.

Take tablets with meals to reduce gastrointestinal upset from metformin and to align glyburide’s glucose-lowering peak with carbohydrate intake.

Carry a reliable source of fast sugar—glucose gel, juice box, or hard candies—for treating hypoglycaemia caused by the glyburide component.

Keep a photo of your prescription label and DIN on your phone, and carry a paper medication list for rural or remote clinic visits where connectivity may be limited.

Bring recent renal function (most recent eGFR), liver tests, a full medication list, provincial health card (for example OHIP, BC PharmaCare or RAMQ), and your preferred pharmacy contact (Shoppers Drug Mart, Rexall, Jean Coutu, London Drugs) to every diabetes appointment.

• Quick Hypoglycaemia Action Plan Checklist: Fast sugar on hand; measure blood glucose; if unconscious call 911; medical ID worn.
• Dosage Adjustment Table: See the dosage table in the Dosage & Adjustments section below.
• Contraindications Summary: Severe renal impairment (eGFR <30 mL/min), Type 1 diabetes, metabolic acidosis, known allergy to metformin or glyburide, pregnancy and lactation generally not recommended.

Everyday Use & Best Practices

Morning Versus Evening Dosing In Canadian Routines

Most people take once- or twice-daily dosing aligned to their main meals, commonly with breakfast and supper in a typical Canadian routine.

Start at the lowest prescribed dose such as 1.25mg/250mg once daily and titrate per clinician advice, usually every two weeks while monitoring blood glucose.

For twice-daily regimens, many patients take a larger morning dose with breakfast and a smaller evening dose with supper to match activity and carbohydrate intake.

Shift workers should align doses to their two largest meals rather than clock time to reduce hypoglycaemia risk during long wake periods.

Use pharmacy blister packs, smartphone alarms, or dose reminder apps to track timing, which is especially helpful for people in rural areas with less frequent clinic access.

• Checklist For Dosing Schedule: Set alarm for each dose; log blood sugars for two weeks after a dose change; carry spare dose card in wallet.
• Smartphone Alarm Setup: Use labelled alarms (e.g., "Metformin/Glyburide — Breakfast") and confirm time zones when travelling.

Taking With Or Without Meals (Canadian Diet Context)

Always take metformin/glyburide with food to reduce gastrointestinal effects and to align glyburide onset with mealtime carbohydrates.

Plan doses around typical Canadian meals such as oatmeal and toast for breakfast, a sandwich or salad for lunch, and a cooked dinner, to keep dosing times consistent day-to-day.

If you dine out or travel across time zones, maintain roughly 12 hours between doses for twice-daily regimens rather than forcing exact local clock times.

When a meal will be delayed or missed, skip the glyburide-containing dose if the delay is long, and check capillary glucose before deciding—this reduces hypoglycaemia risk.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

People with severe renal impairment (eGFR <30 mL/min) should not take metformin/glyburide because metformin can accumulate and cause lactic acidosis.

Do not use this combination in Type 1 diabetes or during diabetic ketoacidosis.

Known hypersensitivity to either metformin or glyburide is an absolute contraindication.

Use is not recommended in hepatic impairment, pregnancy or breastfeeding unless directed by a specialist with clear monitoring plans.

Elderly patients need conservative starts and frequent renal monitoring because both hypoglycaemia and lactic acidosis risk rise with age and renal decline.

• Contraindications Checklist: eGFR <30 mL/min; Type 1 diabetes; metabolic acidosis; allergy to metformin or glyburide; pregnancy/lactation cautions.

Activities To Limit (Driving, Workplace Safety)

Glyburide can cause hypoglycaemia and unpredictable low-glucose events, so avoid driving or operating heavy machinery until you know how this medicine affects you.

Workers in safety-sensitive roles such as commercial drivers or heavy-equipment operators should inform occupational health; provincial regulators may require documentation or restrictions.

Avoid excessive alcohol intake because alcohol increases the risk of lactic acidosis with metformin and may worsen hypoglycaemia with glyburide.

Dosage & Adjustments

General Regimen (DIN References)

Typical starting doses are 1.25mg/250mg once or twice daily with meals, with tablet strengths commonly 1.25/250, 2.5/500 and 5/500 mg.

Clinicians usually titrate dose roughly every two weeks to reach glycaemic targets while watching for hypoglycaemia and GI intolerance.

The maximum total daily dose is 20mg glyburide and 2000mg metformin (equivalent to the 20mg/2000mg combined total across tablets).

Ask your pharmacist for the exact product DIN and manufacturer (for example Apotex or Sandoz) and record it for refills and adverse event reports.

Special Cases (Elderly, Comorbidities)

User Testimonials

Positive Reports From Canadian Patients

Many Canadian patients report easier adherence when switched to a single pill combining glyburide and metformin because it reduces pill burden and simplifies morning routines.

Patients often describe a stable morning routine when the pill is taken with breakfast and an observable reduction in fasting glucose after careful titration.

Rural patients especially appreciate fewer pharmacy trips when using longer fills and mail delivery through major chains like Shoppers Drug Mart or London Drugs.

Common Challenges In Forums

• Hypoglycaemia episodes triggered by missed meals or increased physical activity.
• Gastrointestinal upset when starting the metformin component, often improving after a few weeks.
• Confusion with dose timing during travel or shift work leading to missed or doubled doses.
• Some patients prefer metformin alone or newer combinations (SGLT2/DPP-4) because they carry lower hypoglycaemia risk.

Forum comments are useful for shared experience but always check with your prescriber before changing therapy.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Combination tablets are stocked at major Canadian pharmacy chains and community pharmacies, with generics from manufacturers such as Apotex and Sandoz predominating.

Ask your pharmacist for the DIN, exact manufacturer name, and whether a generic substitution is available or required by your provincial plan.

For rural customers, order-ahead and mail-delivery services from national chains can help maintain continuous supply.

Price Comparison (In-Store Vs Online, Cross-Border Notes)

In our online pharmacy, metformin glyburide is available with a prescription and with discreet delivery to Canada in 5–14 days.

What’s Inside & How It Works

Ingredients Overview

Each tablet contains two active ingredients: glyburide, a sulfonylurea that increases insulin secretion, and metformin, a biguanide that reduces hepatic glucose production and improves insulin sensitivity.

Common tablet strengths are 1.25/250, 2.5/500 and 5/500 mg as listed in product specifications.

Generics dominate the market in Canada; common manufacturers include Apotex and Sandoz.

Mechanism Basics

• Glyburide stimulates pancreatic beta cells to increase insulin release, which lowers postprandial blood glucose.
• Metformin decreases hepatic gluconeogenesis and improves peripheral insulin sensitivity, lowering fasting glucose.
• The combination targets two pathophysiological defects in Type 2 diabetes: impaired insulin secretion and insulin resistance.
• Because glyburide is a secretagogue, hypoglycaemia risk is higher than with non-secretagogue combinations.

Main Indications

Approved Uses In Canada

Combination glyburide/metformin tablets are indicated for adults with Type 2 diabetes who need dual oral therapy when diet, exercise and monotherapy are inadequate for glycaemic control.

Confirm the Health Canada-authorised product and DIN with your pharmacist before starting treatment.

Off-Label Uses By Canadian Physicians

Some clinicians may use combination therapy selectively when dual oral therapy is appropriate, but it is not approved for Type 1 diabetes, children, pregnancy or lactation.

Specialists may prefer alternatives such as metformin plus SGLT2 or DPP-4 inhibitors if cardiovascular or renal benefits are a priority for the patient.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Avoid binge drinking because alcohol increases risk of lactic acidosis with metformin and can worsen hypoglycaemia related to glyburide.

Caffeine does not have major direct interactions, but caffeinated stimulants can mask hypoglycaemia symptoms like fatigue and sweating.

Keep carbohydrate intake consistent around doses to reduce hypoglycaemia risk.

Drug Conflicts (Health Canada Database)

Latest Evidence & Insights

Canadian And International Research Highlights

Clinical literature confirms metformin as first-line therapy and shows that adding a sulfonylurea such as glyburide lowers HbA1c more rapidly than metformin alone while increasing hypoglycaemia risk.

Canadian guideline summaries increasingly favour agents with proven cardiovascular and renal benefits, but sulfonylureas remain a cost-effective option for glycaemic lowering in many patients.

Practical Takeaway For Patients

For Canadians on a limited budget or intolerant of newer agents, glyburide/metformin is a reasonable option when renal function is adequate and close monitoring for hypoglycaemia is in place.

Discuss your cardiovascular and renal history with your prescriber because alternative therapies may be preferred when specific protective benefits are needed.

Alternative Choices

Comparable Medicines

• Metformin monotherapy (for example Glucophage, Siofor).
• Metformin plus a DPP‑4 inhibitor (for example sitagliptin + metformin).
• Metformin plus an SGLT2 inhibitor (for example empagliflozin + metformin).
• Other sulfonylureas such as gliclazide or glimepiride.

Pros / Cons Checklist

• Glyburide/Metformin: Pro — low cost and effective HbA1c lowering; Con — higher hypoglycaemia risk, not ideal with CKD.
• Metformin + SGLT2: Pro — cardiovascular and renal benefits for many patients; Con — higher cost and variable coverage.
• Metformin + DPP‑4: Pro — low hypoglycaemia risk; Con — more modest HbA1c reduction than sulfonylureas in some patients.

Regulation Snapshot

Health Canada Approval And DIN Requirements

Combination glyburide/metformin tablets are authorised in Canada with specific DINs; confirm the DIN on your package and with your pharmacist.

Report adverse events to Health Canada’s MedEffect program through your clinician or pharmacist if you suspect a serious side effect.

Provincial Coverage & Reimbursement

FAQ

Common Canadian Patient Questions

Q: Can I drive after taking this pill?

A: Only if you have not experienced hypoglycaemia and your blood glucose is stable; monitor glucose and avoid driving until you are confident the medicine does not cause low readings.

Q: Is it covered by my provincial plan?

A: Coverage varies by province and plan; give your pharmacist the DIN and ask them to check Ontario Drug Benefit, BC PharmaCare or RAMQ listings for your product.

Q: What if I miss a dose?

A: Take as soon as you remember unless it is close to the next scheduled dose; do not double the next dose.

Q: Can I drink alcohol?

A: Limit alcohol because it increases lactic acidosis risk with metformin and can worsen hypoglycaemia risk from glyburide.

Quick Answers And Follow-Up Actions

• Keep a hypoglycaemia kit with glucose gel or juice and wear a medical ID listing metformin/glyburide.
• Maintain an up-to-date medication list and schedule regular renal checks—at least every 3–6 months for elderly patients.
• Seek urgent care for severe dizziness, confusion, trouble breathing, or lactic-acidosis-like symptoms.

Guidelines For Proper Use

Canadian Pharmacist And Provincial Health Authority Recommendations

Follow Diabetes Canada and Health Canada guidance: start at low dose, titrate every ~2 weeks, monitor HbA1c and renal function regularly, and document the DIN for each refill.

Pharmacists should counsel patients on hypoglycaemia recognition, proper storage (20–25°C, protect from moisture) and what to do around iodinated contrast procedures or surgery.

Practical Daily Checklist

Delivery Across Canada (English)